Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative br
- PDF / 202,346 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 31 Downloads / 145 Views
CORRECTION
Open Access
Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells Cristina Alexandra Ciocan-Cartita1†, Ancuta Jurj1†, Oana Zanoaga1, Roxana Cojocneanu1, Laura-Ancuta Pop1, Alin Moldovan1, Cristian Moldovan2, Alina Andreea Zimta2, Lajos Raduly1, Cecilia Pop-Bica1, Mihail Buse2, Liviuta Budisan1, Piroska Virag3, Alexandru Irimie4,5, Sandra Martha Gomes Dias6, Ioana Berindan-Neagoe1,7* and Cornelia Braicu1 Correction to: J Exp Clin Cancer Res 39, 241 (2020) https://doi.org/10.1186/s13046-020-01736-2 Following publication of the original article [1], the authors identified an error in the author name of Sandra Martha Gomes Dias. The incorrect author name is: Sandra Martha Gomez Diaz The correct author name is: Sandra Martha Gomes Dias The author group has been updated above, and the original article has been corrected. No further changes were made to the article. Author details 1 Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania. 2MedFuture Research Center for Advanced Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania. 3Laboratory of Radiotherapy, Radiobiology and Tumor Biology, “Prof. Dr. Ion Chiricuta” Oncology Institute, Cluj-Napoca, Romania. 4 Department of Surgical Oncology and Gynecological Oncology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania. 5 Department of Surgery, “Prof. Dr. Ion Chiricuta” Oncology Institute,
Cluj-Napoca, Romania. 6Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Sao Paulo, 13083–970, Brazil. 7Department of Functional Genomics and Experimental Pathology, “Prof. Dr. Ion Chiricuta” Oncology Institute, Cluj-Napoca, Romania.
Reference 1. Ciocan-Cartita CA, et al. New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells. J Exp Clin Cancer Res. 2020;39:241.
The original article can be found online at https://doi.org/10.1186/s13046020-01736-2. * Correspondence: [email protected] † Cristina Alexandra Ciocan-Cartita and Ancuta Jurj contributed equally to this work. 1 Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania 7 Department of Functional Genomics and Experimental Pathology, “Prof. Dr. Ion Chiricuta” Oncology Institute, Cluj-Napoca, Romania
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are i
Data Loading...
